Compassionate Cancer Care Medical Group

Riverside, California 92501

0 studies enrolling now · 10 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Chemotherapy-Induced Nausea and Vomiting, HER2+ Metastatic Breast Cancer (MBC), Lung Cancer, MPN (Myeloproliferative Neoplasms), Metastatic Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Oral Mucositis, Renal Cell Carcinoma, SARS-CoV-2 Infection, Small Cell Lung Cancer

Studies at this site

• Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) — Running, not enrolling
• Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2 — Stopped early
• BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma — Completed
• Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) — Stopped early
• An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting — Completed
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed
• A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer — Stopped early
• Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) — Completed
• Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis — Completed
• An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting — Completed